Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Nocutil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 286,895Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eton Pharma’s Desmoda Receives Approval in US
    Eton Pharma’s Desmoda Receives Approval in US

    25 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219873

    FDA
    25 Feb 2026
    Share Share
    Eton Pharma's New Drug ET-600 Receives FDA Acceptance
    Eton Pharma's New Drug ET-600 Receives FDA Acceptance

    08 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/08/3111576/0/en/Eton-Pharmaceuticals-Announces-FDA-Acceptance-of-New-Drug-Application-for-ET-600-Desmopressin-Oral-Solution.html

    GLOBENEWSWIRE
    08 Jul 2025
    Share Share
    Eton Pharmaceuticals Submits NDA for Desmopressin Oral Solution
    Eton Pharmaceuticals Submits NDA for Desmopressin Oral Solution

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069026/0/en/Eton-Pharmaceuticals-Announces-Submission-of-NDA-for-ET-600-Desmopressin-Oral-Solution.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Eton Pharmaceuticals Reports Positive Study Results for ET-600
    Eton Pharmaceuticals Reports Positive Study Results for ET-600

    14 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/14/3042855/0/en/Eton-Pharmaceuticals-Announces-Positive-Pivotal-Clinical-Study-Results-for-Product-Candidate-ET-600.html

    GLOBENEWSWIRE
    14 Mar 2025
    Share Share
    Avenacy Launches Desmopressin Acetate Injection In US
    Avenacy Launches Desmopressin Acetate Injection In US

    15 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240415847399/en

    BUSINESSWIRE
    15 Apr 2024
    Share Share
    Gland's Generic Desmopressin Acetate Receives Approval in U.S.
    Gland's Generic Desmopressin Acetate Receives Approval in U.S.

    20 Mar 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216904

    FDA
    20 Mar 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.